Synthesis of ( Z )- N -hydroxy-3-methoxy-3-phenylacrylamide as new selective inhibitor of hepatitis C virus replication

M. V. Kozlov; A. A. Kleymenova; K. A. Konduktorov; A. Z. Malikova; K. A. Kamarova; R. A. Novikov; S. N. Kochetkov

doi:10.1134/S1068162016010076

Synthesis of (Z)-N-hydroxy-3-methoxy-3-phenylacrylamide as new selective inhibitor of hepatitis C virus replication

Autores: Kozlov M.¹, Kleymenova A.¹, Konduktorov K.¹, Malikova A.¹, Kamarova K.¹, Novikov R.¹, Kochetkov S.¹
Afiliações:
1. Engelhardt Institute of Molecular Biology
Edição: Volume 42, Nº 2 (2016)
Páginas: 191-197
Seção: Article
URL: https://journals.rcsi.science/1068-1620/article/view/227875
DOI: https://doi.org/10.1134/S1068162016010076
ID: 227875

Citar

Texto integral

Acesso aberto
Acesso é fechado

Acesso está concedido
Acesso é fechado

Somente assinantes

Resumo
Sobre autores
Bibliografia
Estatísticas

Resumo

According to recently published results, cinnamic hydroxamic acid (CHA) inhibits replication of hepatitis C virus (HCV). We synthesized a structural analogue of CHA, i.e., (Z)-N-hydroxy-3-methoxy3-phenylacrylamide, which inhibited HCV replication five times more selectively than CHA. It was found that both compounds did not inhibit deacetylation of Ac-α-tubulin with histone deacetylase 6, the activity of which is important for virus replication.